Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.

Casado E, Garcia VM, Sánchez JJ, Gómez Del Pulgar MT, Feliu J, Maurel J, Castelo B, Moreno Rubio J, López RA, García-Cabezas MÁ, Burgos E, de Castro J, Belda-Iniesta C, López-Gómez M, Gómez-Raposo C, Zambrana F, Sereno M, Fernández-Martos C, Vázquez P, Lacal JC, González-Barón M, Cejas P.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1151-8. doi: 10.1016/j.ijrobp.2012.01.083. Epub 2012 Apr 18.

PMID:
22516806
2.

Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy.

Cejas P, López-Gómez M, Aguayo C, Madero R, Moreno-Rubio J, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Moreno García V, Díaz E, Burgos E, Gonzalez-Barón M, Feliu J.

Curr Cancer Drug Targets. 2012 Feb;12(2):124-31.

PMID:
22229245
3.

Development and validation of a prognostic nomogram for terminally ill cancer patients.

Feliu J, Jiménez-Gordo AM, Madero R, Rodríguez-Aizcorbe JR, Espinosa E, Castro J, Acedo JD, Martínez B, Alonso-Babarro A, Molina R, Cámara JC, García-Paredes ML, González-Barón M.

J Natl Cancer Inst. 2011 Nov 2;103(21):1613-20. doi: 10.1093/jnci/djr388. Epub 2011 Oct 4.

PMID:
21972226
4.

A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer.

Casado E, García VM, Sánchez JJ, Blanco M, Maurel J, Feliu J, Fernández-Martos C, de Castro J, Castelo B, Belda-Iniesta C, Sereno M, Sánchez-Llamas B, Burgos E, García-Cabezas MÁ, Manceñido N, Miquel R, García-Olmo D, González-Barón M, Cejas P.

Clin Cancer Res. 2011 Jun 15;17(12):4145-54. doi: 10.1158/1078-0432.CCR-10-2257. Epub 2011 Apr 5.

5.

Irinotecan-cetuximab-bevacizumab as a salvage treatment in heavily pretreated metastatic colorectal cancer patients: a retrospective observational study.

Feliu Batlle J, Cuadrado E, Castro J, Caldés T, Belda C, Sastre J, Barriuso J, Martínez Marín V, Díaz-Rubio E, González-Barón M.

Chemotherapy. 2011;57(2):138-44. doi: 10.1159/000323624. Epub 2011 Mar 30.

PMID:
21447947
6.

Can this patient be discharged home? Factors associated with at-home death among patients with cancer.

Alonso-Babarro A, Bruera E, Varela-Cerdeira M, Boya-Cristia MJ, Madero R, Torres-Vigil I, De Castro J, González-Barón M.

J Clin Oncol. 2011 Mar 20;29(9):1159-67. doi: 10.1200/JCO.2010.31.6752. Epub 2011 Feb 22.

7.

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer.

Feliu J, Borrega P, León A, López-Gómez L, López M, Castro J, Belda-Iniesta C, Barriuso J, Martínez V, González-Barón M.

Cancer Chemother Pharmacol. 2011 Jan;67(1):215-21. doi: 10.1007/s00280-010-1472-0. Epub 2010 Oct 7.

PMID:
20927525
8.

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.

García VM, Batlle JF, Casado E, Burgos E, de Castro J, Belda C, Barriuso J, Sánchez JJ, García-Cabezas MÁ, González-Barón M, Cejas P.

Colorectal Dis. 2011 Sep;13(9):989-98. doi: 10.1111/j.1463-1318.2010.02386.x.

PMID:
20718834
9.

An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer.

Sánchez-Navarro I, Gámez-Pozo A, Pinto A, Hardisson D, Madero R, López R, San José B, Zamora P, Redondo A, Feliu J, Cejas P, González Barón M, Angel Fresno Vara J, Espinosa E.

BMC Cancer. 2010 Jun 28;10:336. doi: 10.1186/1471-2407-10-336.

10.

Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.

Sánchez-Navarro I, Gámez-Pozo A, González-Barón M, Pinto-Marín A, Hardisson D, López R, Madero R, Cejas P, Mendiola M, Espinosa E, Vara JA.

Biotechniques. 2010 May;48(5):389-97. doi: 10.2144/000113388.

11.

Palliative care is a key component of daily practice in oncology: descriptive study of hospitalisation events at an oncology treatment centre.

Espinosa E, Pinto A, Zamora P, Feliu J, Martínez B, González Barón M.

Support Care Cancer. 2010 Sep;18(9):1231-4. doi: 10.1007/s00520-010-0903-0. Epub 2010 May 28.

PMID:
20508952
12.

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.

Feliu J, Safont MJ, Salud A, Losa F, García-Girón C, Bosch C, Escudero P, López R, Madroñal C, Bolaños M, Gil M, Llombart A, Castro-Carpeño J, González-Barón M.

Br J Cancer. 2010 May 11;102(10):1468-73. doi: 10.1038/sj.bjc.6605663. Epub 2010 Apr 27.

13.

mTOR pathway inhibition in renal cell carcinoma.

Pinto Marín A, Redondo Sánchez A, Espinosa Arranz E, Zamora Auñón P, Castelo Fernández B, González Barón M.

Urol Oncol. 2012 Jul-Aug;30(4):356-61. doi: 10.1016/j.urolonc.2009.11.008. Epub 2010 Mar 5. Review.

PMID:
20207176
14.

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.

Cejas P, López-Gómez M, Aguayo C, Madero R, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Moreno García V, Larrauri J, López R, Casado E, Gonzalez-Barón M, Feliu J.

PLoS One. 2009 Dec 18;4(12):e8199. doi: 10.1371/journal.pone.0008199.

15.

Intra-abdominal desmoplastic small round cell tumour in a 39-year-old man.

Pinto Marín A, Garrido Arévalo M, Redondo Sánchez A, Espinosa Arranz E, Zamora Auñón P, González Barón M.

Clin Transl Oncol. 2009 Nov;11(11):770-2.

PMID:
19917543
16.

Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.

Alberola Candel V, Carrato Mena A, Díaz-Rubio García E, Gascón Vilaplana P, González Barón M, Martín Jiménez M, Alba Conejo E, Cassinello Espinosa J, Colomer R, Cruz Hernández JJ, Barnadas i Molins A, Camps Herrero C, Casas Fernández de Tejerina AM, Carulla Torrent J, Constenla Figueiras M, Gavilá Gregori J, Isla Casado MD, Massuti Sureda B, Provencio Pulla M, Rodríguez Sánchez CA, Sanz Ortiz J; Spanish Society of Medical Oncology.

Clin Transl Oncol. 2009 Nov;11(11):727-36.

PMID:
19917536
17.

MALDI profiling of human lung cancer subtypes.

Gámez-Pozo A, Sánchez-Navarro I, Nistal M, Calvo E, Madero R, Díaz E, Camafeita E, de Castro J, López JA, González-Barón M, Espinosa E, Fresno Vara JA.

PLoS One. 2009 Nov 5;4(11):e7731. doi: 10.1371/journal.pone.0007731.

18.

MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.

Cortes-Sempere M, Chattopadhyay S, Rovira A, Rodriguez-Fanjul V, Belda-Iniesta C, Tapia M, Cejas P, Machado-Pinilla R, Manguan-García C, Sánchez-Pérez I, Nistal M, Moratilla C, de Castro-Carpeño J, Gonzalez-Barón M, Albanell J, Perona R.

Cancer Lett. 2009 Dec 28;286(2):206-16. doi: 10.1016/j.canlet.2009.05.029. Epub 2009 Jun 23.

PMID:
19553005
19.

Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer.

Espinosa E, Sánchez-Navarro I, Gámez-Pozo A, Marin AP, Hardisson D, Madero R, Redondo A, Zamora P, San José Valiente B, Mendiola M, González Barón M, Fresno Vara JA.

PLoS One. 2009 Jun 15;4(6):e5911. doi: 10.1371/journal.pone.0005911.

20.

A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas.

Hernando E, Sarmentero-Estrada J, Koppie T, Belda-Iniesta C, Ramírez de Molina V, Cejas P, Ozu C, Le C, Sánchez JJ, González-Barón M, Koutcher J, Cordón-Cardó C, Bochner BH, Lacal JC, Ramírez de Molina A.

Oncogene. 2009 Jul 2;28(26):2425-35. doi: 10.1038/onc.2009.91. Epub 2009 May 18.

21.

Chemotherapy for colorectal cancer in the elderly: Whom to treat and what to use.

Feliu J, Sereno M, Castro JD, Belda C, Casado E, González-Barón M.

Cancer Treat Rev. 2009 May;35(3):246-54. doi: 10.1016/j.ctrv.2008.11.004. Epub 2009 Apr 2. Review.

PMID:
19345021
22.

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy.

Moreno García V, Cejas P, Blanco Codesido M, Feliu Batlle J, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Sánchez JJ, Larrauri J, González-Barón M, Casado E.

Int J Colorectal Dis. 2009 Jul;24(7):741-8. doi: 10.1007/s00384-009-0682-6. Epub 2009 Mar 4.

PMID:
19259690
23.

[Superior vena cava syndrome].

Pinto Marín A, González Barón M.

Med Clin (Barc). 2009 Feb 14;132(5):195-9. doi: 10.1016/j.medcli.2008.06.012. Epub 2009 Feb 7. Spanish. No abstract available.

PMID:
19211087
24.

Aurora kinases as prognostic biomarkers in ovarian carcinoma.

Mendiola M, Barriuso J, Mariño-Enríquez A, Redondo A, Domínguez-Cáceres A, Hernández-Cortés G, Pérez-Fernández E, Sánchez-Navarro I, Vara JA, Suárez A, Espinosa E, González-Barón M, Palacios J, Hardisson D.

Hum Pathol. 2009 May;40(5):631-8. doi: 10.1016/j.humpath.2008.10.011. Epub 2009 Jan 20.

PMID:
19157502
25.

Pancreatic glucagonoma presenting as a pulmonary mass.

Pinto Marín A, Hernández Agudo E, Feliú J, González Barón M.

Clin Transl Oncol. 2009 Jan;11(1):60-2.

PMID:
19155206
26.

Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma.

Mendiola M, Barriuso J, Redondo A, Mariño-Enríquez A, Madero R, Espinosa E, Vara JA, Sánchez-Navarro I, Hernández-Cortes G, Zamora P, Pérez-Fernández E, Miguel-Martín M, Suárez A, Palacios J, González-Barón M, Hardisson D.

PLoS One. 2008;3(12):e4051. doi: 10.1371/journal.pone.0004051. Epub 2008 Dec 29.

27.

Employment in a cohort of cancer patients in Spain. A predictive model of working outcomes.

Molina R, Feliu J, Villalba A, San José B, Jiménez AM, Espinosa E, Alvarez-Mon M, González-Barón M.

Clin Transl Oncol. 2008 Dec;10(12):826-30.

PMID:
19068455
28.

TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer.

Valdés-Mora F, Gómez del Pulgar T, Bandrés E, Cejas P, Ramírez de Molina A, Pérez-Palacios R, Gallego-Ortega D, García-Cabezas MA, Casado E, Larrauri J, Nistal M, González-Barón M, García-Foncillas J, Lacal JC.

Ann Surg Oncol. 2009 Jan;16(1):78-87. doi: 10.1245/s10434-008-0166-x. Epub 2008 Nov 11.

PMID:
19002529
29.

Idiopathic and recurrent thromboembolic phenomena in cancer patients.

López-Gómez M, Gómez-Raposo C, Sereno Moyano M, Casado-Sáenz E, Feliú Batlle J, Ortega Ruipérez C, González Barón M.

Clin Transl Oncol. 2008 Oct;10(10):665-9.

PMID:
18940748
30.

Molecular biology of pancreatic cancer.

Belda-Iniesta C, Ibáñez de Cáceres I, Barriuso J, de Castro Carpeño J, González Barón M, Feliú J.

Clin Transl Oncol. 2008 Sep;10(9):530-7. Review.

PMID:
18796369
31.

HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence.

Ortega AD, Sala S, Espinosa E, González-Barón M, Cuezva JM.

Carcinogenesis. 2008 Nov;29(11):2053-61. doi: 10.1093/carcin/bgn185. Epub 2008 Aug 6.

PMID:
18687667
32.

Employment in a cohort of breast cancer patients.

Molina Villaverde R, Feliu Batlle J, Villalba Yllan A, Jiménez Gordo AM, Redondo Sánchez A, San Jose Valiente B, Gonzalez Baron M.

Occup Med (Lond). 2008 Oct;58(7):509-11. doi: 10.1093/occmed/kqn092. Epub 2008 Jul 30.

PMID:
18667388
33.

Primary cardiac osteosarcoma.

López M, Pinto A, Moreno V, Díaz M, González Barón M.

Clin Transl Oncol. 2008 Aug;10(8):515-6.

PMID:
18667384
34.

Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism.

Gómez Del Pulgar T, Valdés-Mora F, Bandrés E, Pérez-Palacios R, Espina C, Cejas P, García-Cabezas MA, Nistal M, Casado E, González-Barón M, García-Foncillas J, Lacal JC.

Int J Oncol. 2008 Jul;33(1):185-93.

PMID:
18575765
35.

Study of the prevalence of tumour-related asthenia in Spanish cancer patients.

González Barón M, Feyjóo M, Carulla Torrent J, Camps C, Escobar Y, Belda-Iniesta C.

Clin Transl Oncol. 2008 Jun;10(6):351-8.

PMID:
18558582
36.

Descriptive analysis of clinical factors affecting terminally ill cancer patients.

Jiménez-Gordo AM, Feliu J, Martínez B, de-Castro J, Rodríguez-Salas N, Sastre N, Vilches Y, Espinosa E, Rodríguez-Aizcorbe JR, González-Barón M.

Support Care Cancer. 2009 Mar;17(3):261-9. doi: 10.1007/s00520-008-0460-y. Epub 2008 Jun 5.

PMID:
18528716
37.

An epidemiological study of the perception of asthenia by oncologists in cancer patients: POA study.

González Barón M, Feijóo M, Escobar Alvarez Y; ASTHENOS Group.

Clin Transl Oncol. 2008 May;10(5):288-93.

PMID:
18490246
38.

Retroperitoneal Castleman's disease with colon cancer. A rare association.

Gómez-Raposo C, Nistal M, De Castro Carpeño J, Sosa Rotundo G, Belda-Iniesta C, Casado E, González Barón M.

Clin Transl Oncol. 2008 Apr;10(4):238-40.

PMID:
18411199
39.

Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study.

Feliu J, Firvida JL, Castro J, Madroñal C, Rodríguez-Jaráiz A, Salgado M, Belda-Iniesta C, Casado E, García-Mata J, González-Barón M; Oncopaz Cooperative Group.

Cancer Chemother Pharmacol. 2009 Feb;63(3):403-9. doi: 10.1007/s00280-008-0749-z. Epub 2008 Apr 9.

PMID:
18398610
40.

UFT (tegafur-uracil) in rectal cancer.

Casado E, Pfeiffer P, Feliu J, González-Barón M, Vestermark L, Jensen HA.

Ann Oncol. 2008 Aug;19(8):1371-8. doi: 10.1093/annonc/mdn067. Epub 2008 Apr 1. Review.

PMID:
18381370
41.

Meningeal relapse by follicular lymphoma as a single mass.

Moreno García V, Redondo A, Fernández Zubillaga A, González-Barón M.

Clin Transl Oncol. 2008 Mar;10(3):180-1.

PMID:
18321822
42.

Cirrhosis-like radiological pattern in patients with breast cancer.

Gómez Raposo C, Redondo Sánchez A, Guerra-Gutiérrez F, Castelo Fernández B, Gómez Senent S, Espinosa Arranz E, Martínez Martínez B, Zamora Auñón P, González Barón M.

Clin Transl Oncol. 2008 Feb;10(2):111-6.

PMID:
18258510
43.

Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach.

Belda-Iniesta C, de Castro Carpeño J, Sereno M, González-Barón M, Perona R.

Clin Transl Oncol. 2008 Feb;10(2):73-7. Review.

PMID:
18258505
44.

Cardiac toxicity: old and new issues in anti-cancer drugs.

Sereno M, Brunello A, Chiappori A, Barriuso J, Casado E, Belda C, de Castro J, Feliu J, González-Barón M.

Clin Transl Oncol. 2008 Jan;10(1):35-46. Review.

PMID:
18208791
45.

EGFR and colon cancer: a clinical view.

de Castro-Carpeño J, Belda-Iniesta C, Casado Sáenz E, Hernández Agudo E, Feliu Batlle J, González Barón M.

Clin Transl Oncol. 2008 Jan;10(1):6-13. Review.

PMID:
18208787
46.

Brain metastases as the first sign of colon cancer.

Gómez Raposo C, Mora Rillo M, Gómez Senent S, Robles Maruhenda A, Montoya F, García Puig J, González Barón M.

Clin Transl Oncol. 2007 Nov;9(11):742-3.

PMID:
18055330
47.

Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells.

Belda-Iniesta C, Perona R, Carpeño Jde C, Cejas P, Casado E, Manguan-García C, Ibanez de Caceres I, Sanchez-Perez I, Andreu FB, Ferreira JA, Aguilera A, de la Peña J, Perez-Sánchez E, Madero R, Feliu J, Sereno M, González-Barón M.

Cancer Biol Ther. 2007 Oct;6(10):1600-5. Epub 2007 Jul 12.

PMID:
17938574
48.

Molecular markers in colorectal cancer: genetic bases for a customised treatment.

Casado E, De Castro J, Belda-Iniesta C, Cejas P, Feliu J, Sereno M, González-Barón M.

Clin Transl Oncol. 2007 Sep;9(9):549-54. Review.

PMID:
17921101
49.

Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.

Ramírez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, Tarón M, Ramírez de Molina V, Cejas P, Skrzypski M, Gallego-Ortega D, de Castro J, Casado E, García-Cabezas MA, Sánchez JJ, Nistal M, Rosell R, González-Barón M, Lacal JC.

Lancet Oncol. 2007 Oct;8(10):889-97.

PMID:
17851129
50.

New screening method for lung cancer by detecting volatile organic compounds in breath.

Belda-Iniesta C, de Castro Carpeño J, Carrasco JA, Moreno V, Casado Sáenz E, Feliu J, Sereno M, García Río F, Barriuso J, González Barón M.

Clin Transl Oncol. 2007 Jun;9(6):364-8. Review.

PMID:
17594950

Supplemental Content

Loading ...
Support Center